Summary

Description

Making clinical audit data transparent. In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. Each year data from the National Head and Neck Cancer Audit will be made available in CSV format. The data are also being made available on the data.gov website. What information is being made available? Audit participation by NHS Trust and data completeness for the key fields. Measures of aspects of the care given to patients. Information about care outcomes and treatment. Trusts and Networks are identified by name and their national code. These data do not list individual patient information, nor do they contain any patient identifiable data. The National Head and Neck Cancer Audit focuses on cancer sites within the head and neck (excluding tumours of the brain and thyroid cancers). The most common of which are the larynx, oropharynx and in the oral cavity. The National Head and Neck Cancer Audit is commissioned and sponsored by the Healthcare Quality Improvement Partnership (HQIP) and developed in partnership with the British Association of Head and Neck Oncologists (BAHNO). The Health and Social Care Information Centre provides project management and technical infrastructure. The National Head and Neck Cancer Audit 2012, Eighth Annual Report provided information that represents 7726 cases of head and neck cancer from England and 546 cases from Wales. The report, therefore, represents a comprehensive overview of head and neck cancer care, and this supporting dataset contains those England indicators in the report. The National Head and Neck Cancer Audit 2011-2012 covers the time period from 1st November 2011 to 31st October 2012. Trusts and networks within England are included.

Summary

Description

The outcome of hip fracture serves as a key marker of the quality of hospital care across the many disciplines and departments who collaborate before, during and after this operation. However, the immediate physiological stress experienced by these patients is the pain and blood loss associated with the fracture. High quality anaesthetic care is crucial to the effective management of both stresses. Clinicians interested in promoting better anaesthetic management of patients with hip fracture came together in 2007. The Hip Fracture Perioperative Network (HipPeN) grew from this, and produced a report in 2010 highlighting wide variations in anaesthetic practice. HipPeN has since completed several projects – leading to publication of the Association of Anaesthetists of Great Britain and Ireland (AAGB&I) guidelines on the anaesthetic management of hip fracture in 2012. The National Hip Fracture Database (NHFD) is the largest hip fracture database in the world. The database includes surgical and mortality data on a third of a million patients. It captures 95% of all new cases of hip fracture, with data from all hospitals in England, Wales, Northern Ireland and the Channel Islands, and provides an ideal infrastructure for large audits. Public funding was provided through the Healthcare Quality Improvement Partnership (HQIP); the NHFD has now been incorporated into the Falls and Fragility Fracture Audit Programme (FFFAP) administered by the Royal College of Physicians (RCP). Collaboration between the AAGB&I and the NHFD culminated in this 2014 report which profiles approaches to peri-operative care across England, Wales and Northern Ireland. ASAP set out to collect data on everyone over the age of 60 who had hip fracture surgery in hospitals across England, Wales and Northern Ireland between 1st May and 31st July 2013. The aim of ASAP was to profile individual hospitals’ compliance with the standards for peri-operative care defined by the National Institute of Health and Care Excellence (NICE) in 2011, and the Association of Anaesthetists of Great Britain and Ireland (AAGB&I) in 2012. The audit covers England, Wales, Northern Ireland, the Isle of Man and the Channel Islands, however data files only refer to data for England.

Summary

Description

This dataset shows individual trust- and unit-level activity and outcomes for hip and knee replacement surgery in 2012 for the NHS and private sector. It has been reproduced from the full NJR 10th Annual Report 2013 and covers the specific period January to December 2012. The data published on this page only applies to England. The National Joint Registry of England, Wales and Northern Ireland (NI) publishes data from all territories, where achievable, as part of annual reporting process. The full NJR 10th Annual Report includes 2012 results for Welsh Health Boards (NI joined in Feb 2013). The data shows information relating to how individual trusts and hospitals in England have performed against a range of key measures including whether they have been identified as an ‘outlier’ for mortality and revision rates. Key measures: Hospitals have been awarded a green (≥95%), amber (≥80%) or red (>80%) rating to reflect how well they performed in 2011 based on consent, compliance and linkability. Compliance information is published at trust-level. All other information is published by individual hospital in the NHS and private sector. Outlier analysis: Outlier analysis aims to identify ‘unusual differences’ in data from ‘normal variations’ which may indicate the need for further investigation. For mortality and revision rates, an outlier will be a hospital with an unusually high proportion – more than would normally be expected. Outliers are identified by a 'Y.' The NJR has also listed the following information for each hospital: • Number of consultants • Average ASA grade • Percentage of male patients • Average age at operation • Percentage of 10A rated acetabular hip and femoral hip implants

Summary

Description

This dataset shows individual trust- and unit-level activity and outcomes for hip and knee replacement surgery in 2011 for the NHS and private sector. It has been reproduced from the full NJR 9th Annual Report 2012 and covers the specific period January to December 2011. The data published on this page only applies to England. The National Joint Registry of England, Wales and Northern Ireland (NI) publishes data from all territories, where achievable, as part of annual reporting process. The full NJR 9th Annual Report includes 2011 results for Welsh Health Boards (NI joined in 2013). The data shows information relating to how individual trusts and hospitals in England have performed against a range of key measures including whether they have been identified as an ‘outlier’ for revision rates. Key measures: Hospitals have been awarded a green (≥95%), amber (≥80%) or red (>80%) rating to reflect how well they performed in 2011 based on consent, compliance and linkability. Compliance information is published at trust-level. All other information is published by individual hospital in the NHS and private sector. Outlier analysis: Outlier analysis aims to identify ‘unusual differences’ in data from ‘normal variations’ which may indicate the need for further investigation. For revision rates, an outlier will be a hospital with an unusually high proportion of revision rates – more than would normally be expected. Outliers are identified by a 'Y.' The NJR has also listed the following information for each hospital: • Number of consultants • Average ASA grade • Percentage of male patients • Average age at operation • Percentage of 10A rated acetabular hip and femoral hip implants

Summary

Description

Making clinical audit data transparent In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister restated the commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. The National Lung Cancer Audit (NLCA) was identified as the pilot for this data release. The data was released in an open and standardised format for the first time in December 2011, and each year onward, data from the National Lung Cancer Audit will be made available in CSV format. The data are also being made available on the data.gov website. Covering all Cancer Networks and NHS Trusts in England, the data from the audit includes information about data completeness, audit process and outcome measures. The data will be available in a pdf format with the National Lung Cancer Audit 2012 annual report. What information is being made available? Measures about the process of care given to patients Information about care outcomes and treatment. The data also provides Audit participation by Trust and data completeness for the key fields. This data does not list data about individual patients nor does it contain any patient identifiable data. Using and interpreting the data Data from the National Lung Cancer Audit requires careful interpretation, and the information should not be looked at in isolation when assessing standards of care. Data is analysed either by cancer network or by place first seen in secondary care for the calendar year 2012. As a result, some trusts that only provide some specialist treatments for patients and do not routinely supply diagnostic data are not properly represented in these data. This is because all the analyses of the NLCA to date have been carried out by 'place first seen' and cancer networks. The ‘place first seen' most closely represents the Clinical Multi-Disciplinary Team (MDT) which makes the first treatment decisions (in partnership with representatives from the specialist centres who sit on these peripheral MDTs). We largely know the population base for these MDTs and that number provides the ‘denominator' for the outcome measures. It is much more difficult to define a population denominator for specialist centres and the treatment they provide is usually only one part of a complex care pathway. So taking the raw data at face value gives a very distorted picture both of their activity and performance. Accessing the data The data are being made available on the data.gov website. Each year two files of data from the National Lung Cancer Audit will be made available in CSV format. Trusts and Networks are identified by name and their national code. What does the data cover? The data measure levels of completeness for data submitted to the NLCA and measures of performance in the audit at trust level for key performance measures for assessing standards of care for lung cancer in secondary care. Details of these standards can be found in appendix 2 of the NLCA report. Are all Trusts included? All Trusts in England that manage patients diagnosed with lung cancer (excluding mesothelioma) are included. The audit also covers Wales. What period does the data cover? This data were extracted from the NLCA database in July 2013 and covers patients first seen in the calendar year 2012.

Summary

Description

Making clinical audit data transparent In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister restated the commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. The National Lung Cancer Audit (NLCA) was identified as the pilot for this data release. The data was released in an open and standardised format for the first time in December 2011, the data has been provided annually from then onwards. Covering all Cancer Networks and NHS Trusts in England, the data from the audit includes information about data completeness, audit process and outcome measures. The data will be available in a pdf format in the National Lung Cancer Audit 2011 annual report. What information is being made available? Measures about the process of care given to patients Information about care outcomes and treatment. The data also provides Audit participation by Trust and data completeness for the key fields; These data do not list data about individual patients nor does it contain any patient identifiable data. Using and interpreting the data Data from the National Lung Cancer Audit requires careful interpretation, and the information should not be looked at in isolation when assessing standards of care. Data are analysed either by cancer network or by place first seen in secondary care for the calendar year 2011. As a result, some trusts that only provide some specialist treatments for patients and do not routinely supply diagnostic data are not properly represented in these data. This is because all the analyses of the NLCA to date have been carried out by 'place first seen' and cancer networks. The ‘place first seen' most closely represents the Clinical Multi-Disciplinary Team (MDT) which makes the first treatment decisions (in partnership with representatives from the specialist centres who sit on these peripheral MDTs). We largely know the population base for these MDTs and that number provides the ‘denominator' for the outcome measures. It is much more difficult to define a population denominator for specialist centres and the treatment they provide is usually only one part of a complex care pathway. So taking the raw data at face value gives a very distorted picture both of their activity and performance. Accessing the data The data are being made available on the data.gov website. Each year two files of data from the National Lung Cancer Audit will be made available in CSV format. Trusts and Networks are identified by name and their national code. What does the data cover? The data measure levels of completeness for data submitted to the NLCA and measures of performance in the audit at trust level for key performance measures for assessing standards of care for lung cancer in secondary care. Details of these standards can be found in appendix 2 of the NLCA report. Are all Trusts included? All Trusts in England that manage patients diagnosed with lung cancer or mesothelioma are included. What period does the data cover? This data were extracted from the NLCA database in July 2012 and covers patients first seen in the calendar year 2011.

Summary

Description

Making clinical audit data transparent In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister restated the commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. The National Lung Cancer Audit (NLCA) was identified as the pilot for this data release. These data will be released in an open and standardised format for the first time in December 2011, and provided annually from then onwards. Covering all Cancer Networks and NHS Trusts in England, the data from the audit includes information about data completeness, audit process and outcome measures. The data will be available in a pdf format in the National Lung Cancer Audit 2011 annual report. What information is being made available? Measures about the process of care given to patients Information about care outcomes and treatment. The data also provides Audit participation by Trust and data completeness for the key fields; These data do not list data about individual patients nor does it contain any patient identifiable data. Using and interpreting the data Data from the National Lung Cancer Audit requires careful interpretation, and the information should not be looked at in isolation when assessing standards of care. Data are provided either by cancer network or by place first seen in secondary care for the calendar year 2010. As a result, some trusts that only provide some specialist treatments for patients and do not supply diagnostic data are not properly represented in these data. This is because all the analyses of the NLCA to date have been carried out by 'place first seen' and cancer networks. The ‘place first seen' is the Clinical Multi-Disciplinary Team (MDT) which makes the first treatment decisions (in partnership with representatives from the specialist centres who sit on these peripheral MDTs). We largely know the population base for these MDTs and that number provides the ‘denominator' for the outcome measures. It is much more difficult to define a population denominator for specialist centres and the treatment they provide is usually only one part of a complex care pathway. So taking the raw data at face value gives a very distorted picture both of their activity and performance. Therefore their performance should not be assessed from the results as published here. These trusts do however fully participate in the audit by providing treatment data for the referring MDTs. The trusts concerned are: The Christie NHS Foundation Trust University Hospitals of South Manchester NHS Foundation Trust Clatterbridge Centre for Oncology NHS Foundation Trust Royal Brompton and Harefield NHS Foundation Trust The Royal Marsden NHS Foundation Trust Papworth Hospital NHS Foundation Trust Accessing the data The data are being made available on the data.gov website. Each year two files of data from the National Lung Cancer Audit will be made available in CSV format. Trusts and Networks are identified by name and their national code. What does the data cover? The data measure levels of completeness for data submitted to the NLCA and measures of performance in the audit at trust level for key performance measures for assessing standards of care for lung cancer in secondary care. Details of these standards can be found in appendix 2 of the NLCA report. Are all Trusts included? All Trusts in England that manage patients diagnosed with lung cancer or mesothelioma are included. What period does the data cover? This data were extracted from the NLCA database in July 2011 and covers patients first seen in the calendar year 2010.

Summary

Description

This document contains data from the National Neoantal Audit Programme Annual Report 2011. The audit aims to assess whether babies admitted to neonatal units receive consistent high quality care across England in relation to the audit questions, and identify areas for improvement in relation to delivery and outcomes of care. The cohort covered is babies discharged from a neonatal unit during the calendar year 2011. These data do not contain data about individual patients not do they contain any patient identifiable data.

Summary

Description

Development of the National Register for Social Housing (NROSH) was started by the Department for Communities and Local Government (DCLG) in 2004. NROSH aimed to be a database of all social housing properties in England, with a range of details captured on each property. NROSH was transferred to the Tenant Services Authority, the social housing regulator, in April 2010 and was discontinued in May 2011. Ownership of the latest NROSH dataset passed from the TSA to the Homes and Communities Agency (HCA) when responsibility for social housing regulation passed to the Regulation Committee of the HCA in April 2012. In addition to being out of date, the records submitted by social landlords to NROSH are of varying quantity and quality with many incomplete, inaccurate or missing records. The database may also contain a number of duplicate entries. Two datasets are available. One is the latest NROSH database held by the HCA as at May 2011. This release contains a large subset of the full NROSH dataset (48 from 201 fields in total; for 4,826,417 unique property records). The data in this release does not include those fields where data could enable specific identification of vulnerable people or other sensitive personal data. It also excludes fields where a minimum completion threshold is not met (generally fields where less than 25% of records have data). There are still issues of quality, incomplete data, and potential duplication of records in the data that accompanies this release that HCA is not able to resolve. Additional information, including data that falls below the minimum quality thresholds for this release, may be requested from the HCA (Referrals & Regulatory Enquiries Team, mail@homesandcommunities.co.uk). The 48 fields included in this release are summarised and described in the two tables accompanying this metadata. The data is contained in five compressed single CSV files: NROSH Data Extract Part 1; - 2; - 3; -4 and -5. Due to the large volume of records, analysis will require database software (MS Excel will not support analysis). Also available is a snapshot of the NROSH database held by DCLG as at March 2010. The data is that which was reported by social landlords in line with the system specifications and includes a selected set of fields on property address, type of accommodation, form of structure, number of rooms and bedspaces are included.

Summary

Description

Making clinical audit data transparent In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. Each year data from the National Oesophago-gastric Cancer Audit will be made available in CSV format. The data are also being made available on the data.gov website. What information is being made available? Audit participation by NHS Trust and data completeness for the key fields. Measures about the process of care given to patients. Information about care outcomes and treatment. Trusts and Networks are identified by name and their national code. These data do not list individual patient information, nor do they contain any patient identifiable data. The National Oesophago-Gastric Cancer Audit covers the quality of care given to patients with Oesophago-Gastric (OG) cancer. The audit evaluates the process of care and the outcomes of treatment for all OG cancer patients, both curative and palliative. From April 2012, the audit has been extended to include patients with Oesophageal High-Grade Glandular Dysplasia (HGD). The National Oesophago-gastric Cancer Audit is a high profile, collaborative, national clinical audit for oesophago-gastric cancer run jointly by The Health and Social Care Information Centre, The Association of Upper Gastrointestinal Surgeons of Great Britain & Ireland (AUGIS), British Society of Gastroenterologists (BSG) and The Clinical Effectiveness Unit at the Royal College of Surgeons of England. The audit aims to improve the quality of care and survival of patients with Oesophago-gastric cancer. It meets the requirements as set out in the NHS Cancer Plan and NICE guidelines. The National Oesophago-gastric Cancer Audit 2010/11 covers the time period from 1st April 2010 to 31st March 2011 and only Hospital sites within England are included.

Summary

Description

Making clinical audit data transparent. In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. Each year data from the National Oesophago-gastric Cancer Audit will be made available in CSV format. The data are also being made available on the data.gov website. What information is being made available? Audit participation by NHS Trust and data completeness for the key fields. Measures about the process of care given to patients. Information about care outcomes and treatment. Trusts and Networks are identified by name and their national code. These data do not list individual patient information, nor do they contain any patient identifiable data. The National Oesophago-Gastric Cancer Audit covers the quality of care given to patients with Oesophago-Gastric (OG) cancer. The audit evaluates the process of care and the outcomes of treatment for all OG cancer patients, both curative and palliative. From April 2012, the audit has been extended to include patients with Oesophageal High-Grade Glandular Dysplasia (HGD). The National Oesophago-gastric Cancer Audit is a high profile, collaborative, national clinical audit for oesophago-gastric cancer run jointly by The Health and Social Care Information Centre, The Association of Upper Gastrointestinal Surgeons of Great Britain & Ireland (AUGIS), British Society of Gastroenterologists (BSG) and The Clinical Effectiveness Unit at the Royal College of Surgeons of England. The audit aims to improve the quality of care and survival of patients with Oesophago-gastric cancer. It meets the requirements as set out in the NHS Cancer Plan and NICE guidelines. The National Oesophago-gastric Cancer Audit 2011/12 covers the time period from 1st April 2011 to 31st March 2012 and only Hospital sites within England are included.

Summary

Description

In January 2013, the National Vascular Registry was formed by the amalgamation of the National Vascular Database and the UK Carotid Interventions Audit projects. The Registry was commissioned by the Healthcare Quality Improvement Partnership (HQIP) as part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP) and is based in the Clinical Effectiveness Unit of the Royal College of Surgeons of England. The aim of the Registry is to measure the quality and outcomes of care for patients who undergo vascular surgery in England and Wales. Data on abdominal aortic aneurysm (AAA) has also been collected since 2005 via the same webtool as carotid endarterectomies as part of a broad quality improvement programme undertaken by the Vascular Society in collaboration with other organisations. One part of this programme was the Abdominal Aortic Aneurysm Quality Improvement Programme funded by the Health Foundation (an independent charity) which ran from 2008 until 2013. During this time, the mortality rate following elective infra-renal AAA repair in the United Kingdom fell from 7% to 2.4%. The results presented in the spreadsheets below are for patients undergoing an elective repair of their infra-renal abdominal aortic aneurysm (AAA) between January 2010 and December 2012.

Summary

Description

This dataset comprises a set of analyses concerning the treatment of patients with heart failure by NHS hospitals in England in 2011/12. The data has been reproduced from the National Heart Failure Audit 2012/13 Annual Report. The National Heart Failure Audit monitors the treatment of heart failure patients in England and Wales. It collects data on patients with an unscheduled admission to hospital who are discharged with a primary diagnosis of heart failure. The audit covers all hospitals in England and Wales which admit acute patients with heart failure – the vast majority (92%) of hospitals currently submit data. Only English data are included in this dataset. Analyses are included for every eligible English hospital which submitted at least 50 records to the audit in the 2012/13 audit year. The analyses include: • The number of patients at each hospital discharged with a diagnosis of heart failure • The number of patients within this group with a clinical diagnosis of heart failure • The percentage of patients who received an echo, either during this admission or within the previous 6 months • The percentage of patients who were a cardiology inpatient for the majority of their hospital stay • The percentage of patients who received input from a consultant cardiologist • The percentage of patients who received input from a heart failure specialist (consultant cardiologist, consultant with interest in heart failure, or heart failure nurse specialist) • The percentage of patients who were prescribed an ACE inhibitor on discharge • The percentage of patients who were prescribed an ACE inhibitor or an ARB on discharge • The percentage of patients who were prescribed a beta blocker on discharge • The percentage of patients who received discharge planning • The percentage of patients who were referred to a heart failure nurse follow-up service (covering both all patients, and just those with a diagnosis of left ventricular systolic dysfunction (LVSD)). • The percentage of patients who were referred to follow-up with a cardiologist.

Summary

Description

NHM Spend data for all transactions over £500

Summary

Description

The Annual Fraud Indicator (AFI) is a compendium of fraud loss indicators which strives to provide a best estimate of the scale of the problem and raise awareness. In line with Fighting Fraud Together, the AFI covers fraud against all types of victims in the UK be they public, private, and not-for-profit organisations or individuals. The report brings together existing estimates of fraud in the public domain, and new estimates produced by the NFA which aim to reveal areas of fraud loss that remain hidden from sight.

Summary

Description

The data is a live XML feed from Norfolk County Council's CDMF System (Common Data Management Facility) hosted by the ITS (Intelligent Transport Systems) team. The data is updated every 5 minutes, it is compiled by our CDMF system but sourced from various third party systems. Park and Ride data is provided by our own Norfolk County Council Park and Ride Sites. Private car park data from shopping centres and department stores is provided in good faith by car park operators. The feed gives a capacity and current occupancy of each car park, along with a status of OPEN or CLOSED if appropriate. The data is also published on the Travel Norfolk Website www.norfolk.gov.uk/travelnorfolk

Summary

Description

These files include NHS Bristol and its associated hosted services expenditure over £25,000 on a monthly basis from April 2010 onwards.

Summary

Description

The number of incidents that have been recorded by police forces as crimes, but have then been ‘no crimed’ where it is judged by the police that no crime actually took place.

Summary

Description

Gives details of FCO programme spend under Official Development Aid

Summary

Description

FCO Official Development Assistance through the British Council

Summary

Description

Extents of Open Space Protection in Malvern Hills District Council area. Comprising part of the Local Plan as published in 2006.

Summary

Description

Staff post and payscale information for the Joint Nature Conservation Committee as of 28 September 2012.

Summary

Description

Organisation structure charts (organograms) for High Speed 2. Providing: 1. structure of the department/body down to directorate level 2. positions of all Senior Civil Servant (SCS) Pay Band 2 and above (or equivalent) 3. names of SCS Pay Band 2 and above 4. salaries of all Pay Band 2 and above 5. job titles of SCS Pay Band 1 and 1A (or equivalent) 6. reporting numbers of staff within directorates (FTE) and total salary costs of SCS1 teams. SCS staff salaries - name, grade, job title, FTE, parent department, organisation, unit, actual pay floor, actual pay ceiling. Junior staff FTE - parent department, organisation, unit, reporting SCS, grade, number of posts FTE

Summary

Description

Making clinical audit data transparent In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. Each year data from the National Paediatric Diabetes Audit will be made available in CSV format. The data are also being made available on the data.gov website. What information is being made available? Audit participation by Paediatric unit and data completeness for the key fields. Measures about the process of care given to patients. Information about care outcomes and treatment. Paediatric units are identified by name and their national code. These data do not list individual patient information, nor do they contain any patient identifiable data. The National Paediatric Diabetes Audit is a high profile, collaborative, national clinical audit for paediatric diabetes. The National Paediatric Diabetes Audit was run by the NHS Information Centre up to and including the 2009-10 audit. It is now managed by The Royal College of Paediatrics and Child Health (RCPCH). The audit aims to improve the quality of care in young people with diabetes. It meets the requirements as set out in the NICE guidelines. The National Paediatric Diabetes Audit 2009/10 covers the time period from 1 January 2009 up to 31 March 2010 and specialist paediatric units from England are included.

Summary

Description

Analyses of both time-series (e.g. Labour Force Survey) and regular (e.g. Work-life Balance Employee and Employer surveys) datasets. Supports the impact assessment for draft regulations that extend UK parental leave legislation to comply with EU Directive 2010/18 on Parental Leave by 2013. The Regulations aim to implement the Parental Leave Directive to encourage shared parenting and maintain attachment to the labour market whilst minimising burdens to business. This supports the proposed new system of flexible parental leave due to be introduced in 2015.